Related Experiment Video
Updated: Jan 4, 2026
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Intraoperative breast radiotherapy: survival, local control and risk factors for recurrence
Guilherme Rocha Melo Gondim1, Fabiana Baroni Alves Makdissi1, Ricardo Cesar Fogaroli1
1AC Camargo Cancer Center ⿿ R. Prof. Antônio Prudente, 211 - Liberdade, São Paulo, Brazil.
Background:
Whole breast irradiation reduces loco-regional recurrence and risk of death in patients submitted to breast-conserving treatment. Data show that radiation to the index quadrant alone may be enough in selected patients.
Aim:
To report the experience with intra-operative radiotherapy (IORT) with Electron-beam Cone in Linear Accelerator (ELIOT) and the results in overall survival, local control and late toxicity of patients submitted to this treatment.
Materials And Methods:
147 patients treated with a median follow up of 6.9 years (0.1⿿11.5 years). The actuarial local control and overall survival probabilities were estimated using the Kaplan Meier method. All tests were two-sided and p 0.05 was considered statistically significant.
Results:
Overall survival of the cohort in 5 years, in the median follow up and in 10 years was of 98.3%, 95.1% and 95.1%, respectively, whereas local control in 5 years, in the median follow up and in 10 years was of 96%, 94.9% and 89.5%, respectively. Two risk groups were identified for local recurrence depending on the estrogen or progesterone receptors, axillary or margin status and lymphovascular invasion (LVI) (p = 0.016).
Conclusions:
IORT is a safe and effective treatment. Rigorous selection is important to achieve excellent local control results.
